Share on LinkedInShare on LinkedIn

ARTICLE · 21 DECEMBER 2016

Developments In Norwich Pharmacal In Foreign Proceedings – What You Need To Know

Two recent judgments broaden the Norwich Pharmacal jurisdiction in the BVI, each by the two incumbent Commercial Court justices...

British Virgin IslandsWealth Management

Two recent judgments broaden the Norwich Pharmacal jurisdiction in the BVI, each by the two incumbent Commercial Court justices: the Honourable Justice Malcolm Davis-White [Ag] and the Honourable Justice Gerhard Wallbank [Ag].

In recent years the BVI Commercial Court showed reluctance to grant Norwich Pharmacal orders. Bannister J expressed his view in no uncertain terms that these applications to provide third party disclosure to assist  foreign parties, always against registered agents, were highly onerous. Bannister J's decision in JSC BTA Bank v Fidelity Corporate Services Limited BVI HC (Com) 2010/137 illustrates this, ruling that the activities of a registered agent were not sufficient to meet the threshold test of being "mixed up in the wrongdoing" and that the applicant had to establish "necessity". On appeal in JSC BTA Bank HCVAP 2010/035, the Court of Appeal overturned this decision, finding that registered agents were not mere onlookers and that the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from